W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE ...

W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.

W. L. Gore & Associates' medical business (Gore) has announced the FDA approval of the GORE® VIABAHN® FORTEGRA Venous Stent — ...

THE rationale for venous ligation in pulmonary embolic disease is based on its assumed ability to prevent subsequent emboli from reaching the lungs. The level of the inferior vena cava is now ...

Inferior vena cava (IVC) filters are widely used in patients who cannot take blood thinners. The IVC is the largest vein in the body, running from the legs to the chest. IVC filters keep blood clots ...

The assessment of the inferior vena cava (IVC) and central venous pressure (CVP) has emerged as a pivotal aspect in the optimisation of haemodynamic management across a range of clinical settings.

From the Surgical Service, Gallinger Municipal Hospital. Select the format you want to export the citation of this publication.

Use of inferior vena cava (IVC) filters declined in the United States following a 2010 safety communication from the US Food and Drug Administration (FDA), although the rate of implantation remains ...

PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...